| 注册
首页|期刊导航|中国医学创新|基于阿奇霉素联合头孢噻肟钠治疗肺部感染的临床价值研究

基于阿奇霉素联合头孢噻肟钠治疗肺部感染的临床价值研究

陈浩 蓝露 刘翔

中国医学创新2016,Vol.13Issue(34):62-64,3.
中国医学创新2016,Vol.13Issue(34):62-64,3.DOI:10.3969/j.issn.1674-4985.2016.34.018

基于阿奇霉素联合头孢噻肟钠治疗肺部感染的临床价值研究

The Clinical Effect of Azithromycin Combined with Claforan in Patients of Pulmonary Infection

陈浩 1蓝露 2刘翔1

作者信息

  • 1. 江西中医药大学附属医院 江西 南昌 330006
  • 2. 江西省皮肤病专科医院
  • 折叠

摘要

Abstract

Objective:To investigate the clinical effect of Azithromycin combined with Claforan in patients of pulmonary infection.Method:The patients with admission time successively as the standard 126 cases of pulmonary infection were divided into two groups, 63 cases in each group,the control group was treated with Azithromycin treatment alone,the observation group was added Claforan combined treatment,the treatment effects of two groups were assessed,the disappearance time of clinical symptoms in patients with cough, expectoration, fever, asthma, pulmonary rales, and adverse reactions of two groups were compared.Result:The treatment efficiency of observation group was 96.8% higher than control group of 79.4%,the difference was statistically significant(P<0.05).The patients in the observation group with cough, expectoration, fever, asthma, pulmonary rales and other symptoms disappeared time lower than control group,the difference was statistically significant (P<0.05).The two groups of patients did not show significant adverse reactions during the treatment period. Conclusion:Azithromycin combined with Claforan in patients of pulmonary infection can effectively improve effect,promote the rapid improvement of the symptoms in patients with high safety,it is worthy of clinical promotion.

关键词

阿奇霉素/头孢噻肟钠/肺部感染/不良反应

Key words

Azithromycin/Claforan/Pulmonary infection/Adverse reaction

引用本文复制引用

陈浩,蓝露,刘翔..基于阿奇霉素联合头孢噻肟钠治疗肺部感染的临床价值研究[J].中国医学创新,2016,13(34):62-64,3.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文